Cargando…
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
Ribavirin, once a staple of hepatitis C treatment, has significant drawbacks, including treatment-limiting side effects, the requirement for intensive laboratory monitoring, the need for frequent dose adjustments, and teratogenicity. These factors make it difficult to escalate ribavirin-based HCV tr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
XIA & HE Publishing Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328726/ https://www.ncbi.nlm.nih.gov/pubmed/30637222 http://dx.doi.org/10.14218/JCTH.2018.00007 |